Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the effect of LEO 130852A gel 1% in maintaining skin thickness in healthy skin treated with steroid.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02392130
Study type Interventional
Source LEO Pharma
Contact
Status Completed
Phase Phase 1
Start date March 2015
Completion date June 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4
Enrolling by invitation NCT03683186 - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Phase 3
Active, not recruiting NCT03688191 - Study of Sirolimus in CTD-TP in China Phase 4
Completed NCT00004357 - Absorption of Corticosteroids in Children With Juvenile Dermatomyositis Phase 2
Recruiting NCT04918524 - The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting NCT04993885 - Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies Phase 2
Not yet recruiting NCT05998759 - Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia Phase 2
Recruiting NCT05065814 - Connective Tissue Diseases and Vitamin D Deficiency N/A
Completed NCT03494036 - Effect of Synbiotic on Immune Response, Gut Permeability and Microbiota in Patient With Connective Tissue Disease N/A
Completed NCT03929120 - Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD) Phase 1
Completed NCT00001330 - Study of Silicone-Associated Connective Tissue Diseases N/A
Not yet recruiting NCT05980728 - Connective Tissue Disease Patients With Pulmonary Hypertension
Not yet recruiting NCT04582292 - Laryngeal Manifestations of Connective Tissue Diseases
Recruiting NCT03214263 - Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
Not yet recruiting NCT06104228 - 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) Phase 2
Completed NCT04171362 - The Effect of Connective Tissue Massage in Patients With Migraine N/A
Completed NCT01656278 - An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis N/A
Recruiting NCT04915482 - TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies Phase 2/Phase 3
Recruiting NCT05505409 - Efficacy and Safety of Pirfenidone in CTD-ILD Phase 4
Recruiting NCT02768259 - Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients N/A